114 related articles for article (PubMed ID: 3260127)
1. Characterization of n-butyl alcohol solubilized, breast tumor specific antigens recognized by a human autologous cytotoxic T-cell clone.
Sato T; Sato N; Takahashi S; Okubo M; Yagihashi A; Torigoe T; Takahashi N; Okazaki M; Asaishi K; Kukuchi K
Cancer Res; 1988 Jul; 48(14):3892-7. PubMed ID: 3260127
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction.
Kikuchi K; Okubo M; Sato T; Sato N
Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362
[TBL] [Abstract][Full Text] [Related]
3. Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells.
Sato T; Sato N; Takahashi S; Koshiba H; Kikuchi K
Cancer Res; 1986 Sep; 46(9):4384-9. PubMed ID: 3488124
[TBL] [Abstract][Full Text] [Related]
4. Identification by monoclonal antibody of the tumor antigen of a human autologous breast cancer cell that is involved in cytotoxicity by a cytotoxic T-cell clone.
Okubo M; Sato N; Wada Y; Takahashi S; Torimoto K; Takahashi N; Sato T; Okazaki M; Asaishi K; Kikuchi K
Cancer Res; 1989 Jul; 49(14):3950-4. PubMed ID: 2786747
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor rejection antigen molecules of chemically induced murine colon tumor C-C26.
Sato N; Yagihashi A; Okubo M; Torigoe T; Takahashi S; Sato T; Kikuchi K
Cancer Res; 1987 Jun; 47(12):3147-51. PubMed ID: 3581064
[TBL] [Abstract][Full Text] [Related]
6. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
7. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
[TBL] [Abstract][Full Text] [Related]
9. Partial characterization of n-butanol-solubilized rejection-type antigens of syngeneic murine colon tumors.
Sato N; Kikuchi K
J Natl Cancer Inst; 1985 Apr; 74(4):883-8. PubMed ID: 3857382
[TBL] [Abstract][Full Text] [Related]
10. Immunobiological and biochemical characterization of solubilized rat gliosarcoma cell tumor-associated transplantation antigens.
Khoda H; Uede T; Yamaki T; Ibayashi Y; Sugawara H; Kikuchi K
Jpn J Cancer Res; 1986 Aug; 77(8):833-42. PubMed ID: 2944861
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
Patel SS; Thiele DL; Lipsky PE
J Immunol; 1987 Dec; 139(11):3886-95. PubMed ID: 3500232
[TBL] [Abstract][Full Text] [Related]
12. Extraction of human organ-specific cancer neoantigens from cancer cells and plasma membranes with 1-butanol.
Labateya N; Thomson DM; Durko M; Shenouda G; Robb L; Scanzano R
Cancer Res; 1987 Feb; 47(4):1058-64. PubMed ID: 3100029
[TBL] [Abstract][Full Text] [Related]
13. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Yasumura S; Hirabayashi H; Schwartz DR; Toso JF; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1993 Mar; 53(6):1461-8. PubMed ID: 8443824
[TBL] [Abstract][Full Text] [Related]
14. Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.
van de Griend RJ; Giphart MJ; Van Krimpen BA; Bolhuis RL
J Immunol; 1984 Sep; 133(3):1222-9. PubMed ID: 6205072
[TBL] [Abstract][Full Text] [Related]
15. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
16. Identification of a tumor-associated target antigen, ATM-1, for a human T-cell clone with activated killer activity and its existence in sera of cancer patients.
Kaieda T; Imawari M; Yamasaki Z; Ohnishi S; Koike M; Idezuki Y; Takaku F
Cancer Res; 1988 Sep; 48(17):4848-54. PubMed ID: 3044579
[TBL] [Abstract][Full Text] [Related]
17. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
[TBL] [Abstract][Full Text] [Related]
18. Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Brossart P; Stuhler G; Flad T; Stevanovic S; Rammensee HG; Kanz L; Brugger W
Cancer Res; 1998 Feb; 58(4):732-6. PubMed ID: 9485028
[TBL] [Abstract][Full Text] [Related]
19. Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells.
Pellat-Deceunynck C; Jego G; Harousseau JL; Vié H; Bataille R
Clin Cancer Res; 1999 Mar; 5(3):705-9. PubMed ID: 10100725
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
Jerome KR; Domenech N; Finn OJ
J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
